WHO grants ‘emergency validation’ to Pfizer-BioNTech vaccine | World News - Hindustan Times
close_game
close_game

WHO grants ‘emergency validation’ to Pfizer-BioNTech vaccine

Geneva | ByAgence France-Presse | Posted by Prashasti Singh
Jan 01, 2021 06:13 AM IST

Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.

The World Health Organization on Thursday granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.

Balafia nursing home worker Sogues Sole, 51, receives an injection with a dose of the Pfizer-BioNTech Covid-19 vaccine, as the coronavirus disease (Covid-19) outbreak continues, in Lleida, Spain, December 27, 2020. REUTERS/Albert Gea(REUTERS)
Balafia nursing home worker Sogues Sole, 51, receives an injection with a dose of the Pfizer-BioNTech Covid-19 vaccine, as the coronavirus disease (Covid-19) outbreak continues, in Lleida, Spain, December 27, 2020. REUTERS/Albert Gea(REUTERS)

Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.

Hindustan Times - your fastest source for breaking news! Read now.

Also Read: Covid-19: No data to back UK’s new vaccination plan, says Pfizer

WHO said the Pfizer/BioNTech vaccine was the first to receive its “emergency validation” since the novel coronavirus first broke out in China a year ago.

“This is a very positive step towards ensuring global access to Covid-19 vaccines,” said Mariangela Simao, a top WHO official tasked with ensuring access to medicines.

“But I want to emphasise the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere,” she said in a statement.

WHO said its emergency use listing opens the way for regulators in different countries to approve the import and distribution of the vaccine.

Also Read: California nurse tests positive a week after receiving Pfizer Covid-19 vaccine

It said it also enables UNICEF, which plays a key logistical role in distributing anti-Covid vaccines, and the Pan-American Health Organization to procure the vaccine for countries that need it.

WHO convened its own experts and those from around the world to review the data on the Pfizer/BioNTech vaccine’s “safety, efficacy and quality,” weighing the benefits against the risks.

“The review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO, and that the benefits of using the vaccine to address Covid-19 offset potential risks,” it said.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On